Focus Taiwan App
Download

Diagnostic test for diabetic kidney disease receives EU approval

02/11/2020 03:51 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Feb. 11 (CNA) A clinical test designed by a Taiwanese biotech company that predicts a patient's risk of diabetic kidney disease has been approved for sale in the European Union, the company said Tuesday.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.43